|Page (1) of 1 - 09/13/17||email article||print page|
(September 13, 2017)
DUBLIN--(BUSINESS WIRE)--The "Global Neurodegenerative Disease Market - Growth, Trends, and Forecasts 2017 - 2022" report has been added to Research and Markets' offering.
The prevalence of neurological disorders has been increasing at a constant pace. The increasing awareness among the people about mental disorders and continuous R&D from major market players to find new and effective therapies for treating such disorders are the major market drivers during the period of the forecast. New types of drugs are expected to be launched in the next few years. The existing drugs are to face patent expiries and thus, new players can enter the market.
The market, however, is set to face obstacles due to the complexity of the disorders as well as the fact that the cause of these disorders is unknown most of the times, resulting in poor results for R&D activities. The currently available medications for such diseases and disorders are only successful in providing symptomatic relief. The market, hence, has a high potential for growth and should be tapped at the earliest.
The global neurodegenerative disease market is segmented by the type of indication into Parkinsons Disease, Amyotrophic Lateral Sclerosis, Alzheimers Disease, and Huntington Disease. Out of these, Alzheimers disease is the most prevalent, followed by Parkinsons disease. The drugs used to provide symptomatic relief are broadly classified into N-methyl-D-aspartate receptor antagonists, selective serotonin reuptake inhibitor, and dopamine inhibitors.
- Merck Serono
- Biogen Idec
- TEVA Pharmaceuticals Industries
- Bayer Schering
- Boehringer Ingelheim
- Sanofi S.A.
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Global Neurodegenerative Disease Market -Segmentation
8. Global Neurodegenerative Disease Market by Geography - Regional Share and forecasts
9. Competitive Landscape
10. Company Profiles
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
For more information about this report visit https://www.researchandmarkets.com/research/9f338c/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs
Related Sites: DMN Newswire , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter